Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;846-853.

Slides:



Advertisements
Similar presentations
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Advertisements

Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
Exploring centre variation in RRT provision Dr Clare Castledine UKRR clinical fellow.
The TRial Of Preventing HYpertension (TROPHY) TROPHY.
To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.
Kaplan-Meier analysis of time to recurrent congestive heart failure or death in patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory.
Baseline Prevalence of Metabolic Syndrome and Individual Components Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:
1 Incidence of CNV in the Fellow Eye in the Comparison of Age-related Macular Degeneration Treatments Trial (CATT) Maguire MG, Daniel E, Shah AR, Grunwald.
ACE inhibitors, ARBs and Statins in COPD: High- and Low-Risk Cohorts G. B. John Mancini, et al. J Am Coll Cardiol 2006;47:
Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements Reference:
Antonio Coca, MD, PhD, FRCP, FESC
Dr John Cox Diabetes in Primary Care Conference Cork
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
UK Renal Registry 18th Annual Report
White-coat Hypertension
United States Preventive Services Task Force: Recommendations for ABPM
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
by Nóra Sydó, Tibor Sydó, Karina A
Attenuation of the “White-Coat Effect” by Antihypertensive Treatment and Regression of Target Organ Damage by Gianfranco Parati, Luisa Ulian, Lorena Sampieri,
by Kamyar Kalantar-Zadeh, Ryan D. Kilpatrick, Charles J
Baseline characteristics of patients
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
PREMIER: Rate of hypertension at 18 months
VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =
Hazard ratios (HR) for ESRD or death for 1-SD increase in systolic BP: Home recording vs clinic measurement BP measurement HR for each 1-SD increase.
Diabetes Journal Club March 17, 2011
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Wesley T. O’Neal et al. JACEP 2016;2:
Further exploration of the risk factor associations with either the first or subsequent congestive heart failure (CHF) events using the Prentice, Williams,
Life expectancy and baseline BP: Male participants
Cystatin C levels and risk of death from all causes
Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Comparison of ATPIII and IDF classifications Kaplan Meier survival.
Baseline Characteristics of 400 Women Who Subsequently Developed Incident Hypertension (Case Subjects) and 400 Women Who Remained Free of Hypertension.
Mintu P. Turakhia et al. JACEP 2016;2:
Patient characteristics: American vs Canadian transplant patients
Baseline Characteristics According to Sex
Characteristics of Study Subjects and Events, According to the Quintile of Exposure to Fine Particulate Matter (PM2.5)* - Part I Kristin A. Miller et al.
Anne L. M. Vlek, MD, Yolanda van der Graaf, MD, PhD, Maayke A
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:
Managing Blood Pressure
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Different Office SBP and DBP Categories Mancia G et al Hypertension. 2005;45:1072.
Baseline characteristics of older women (NHS I), younger women (NHS II), and men (HPFS) with a history of hypertension according to thiazide use Eric N.
Clinical Characteristics, Biochemical and Lipid Profiles, and Carotid IMT in 196 Asymptomatic Subjects With Familial Hypercholesterolemia Mireia Junyent,
Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Simvastatin in Patients With Prior Cerebrovascular Disease: HPS
Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.
Volume 75, Issue 1, Pages (January 2009)
EMPA-REG OUTCOME: Cumulative incidence of the primary outcome
Davide Capodanno et al. JCIN 2009;2:
Associations between type of MI and incident HF
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.
Prosthesis–patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: Effect on survival,
Frankel DS, et al. J Am Coll Cardiol. 2009;53:754-62
Increase of physical activity over time associated with lower HF risk
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR
Risk of venous thromboembolism by ABO blood type, factor V Leiden R506Q and prothrombin G20210A mutations among individuals in the Copenhagen General.
Risk of type 2 diabetes as a function of ABCA1 and ABCG1 genotype in CCHS. Hazard ratios were multifactorially adjusted for age, sex, BMI, hypertension,
Multivariable analysis of hospital days and costs for children in the last year of life, by type and number of LT-CCCs. Multivariable analysis of hospital.
Hazard risks for incident dementia by diverse social relationship engagement score. The scores are calculated by adding the number of selected social relationship.
Forest plot shows the risk ratio of masked hypertension (among clinic normotension) to white-coat hypertension (among clinic hypertension). Forest plot.
The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.
Presentation transcript:

Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;846-853

Percentage incidence of CV () and all-cause death () over an average follow-up of 148 months in subjects with various combinations of normality or elevation in office, home, and 24-hour BP Giuseppe Mancia, et al. Hypertension 2006;47;846-853

, unadjusted data; , data adjusted for age and gender Hazard ratios (HR, 95% confidence intervals) for CV death in subjects with white-coat HT, masked HT, or elevations in both in-office and out-of-office BP versus subjects with in-office and out-of-office BP normality , unadjusted data; , data adjusted for age and gender Giuseppe Mancia, et al. Hypertension 2006;47;846-853

Risk of CV or All-Cause Death in Subjects With Various Combinations of Office, Home, and 24-Hour BP Normality or Elevations Giuseppe Mancia, et al. Hypertension 2006;47;846-853

Baseline Demographic and Clinic Variables According to 24-Hour vs Home BP or to No. of BP Elevations Giuseppe Mancia, et al. Hypertension 2006;47;846-853

Unadjusted and age- and gender-adjusted HR for all-cause death , unadjusted data; , data adjusted for age and gender Giuseppe Mancia, et al. Hypertension 2006;47;846-853